Back to Search
Start Over
P1239: TISLELIZUMAB, A PD-1 INHIBITOR FOR RELAPSED/REFRACTORY MATURE T- AND NK-CELL NEOPLASMS: RESULTS FROM A PHASE 2 STUDY
- Source :
- HemaSphere, Vol 6, Pp 1124-1125 (2022)
- Publication Year :
- 2022
- Publisher :
- Wiley, 2022.
- Subjects :
- Diseases of the blood and blood-forming organs
RC633-647.5
Subjects
Details
- Language :
- English
- ISSN :
- 25729241 and 00008478
- Volume :
- 6
- Database :
- Directory of Open Access Journals
- Journal :
- HemaSphere
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.3967a7efb581422cbc12cd98d48e320c
- Document Type :
- article
- Full Text :
- https://doi.org/10.1097/01.HS9.0000847820.72232.2a